[Long-term results of peritonectomy on the patients with peritoneal carcinomatosis].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18219855)

Published in Gan To Kagaku Ryoho on November 01, 2007

Authors

Yutaka Yonemura1, Tatsuo Ikeno, Masaya Shinbo, Seiken Maejima, Akeo Hagiwara, Yoshio Endou, Miura Masahiro, Syun-ichirou Ogura, Peritoneal Surface Malignancy, Treatment Group

Author Affiliations

1: Dept. of Peritoneal Carcinomatosis, Kishiwada Tokushukai-Hospital.

Articles by these authors

Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell (2002) 5.69

Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori. Helicobacter (2002) 1.65

Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery. J Surg Oncol (2009) 1.55

Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol (2006) 1.49

New method for prevention of bile leakage after hepatic resection. J Surg Oncol (2006) 1.25

Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer. Int J Surg Oncol (2012) 1.24

Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach. Am J Surg (2004) 1.16

Cisplatin incorporated in microspheres: development and fundamental studies for its clinical application. J Control Release (2003) 1.08

Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am (2003) 1.08

Primary retroperitoneal mullerian adenocarcinoma. Rare Tumors (2010) 1.06

Time to death and pattern of death in recurrence following curative resection of gastric carcinoma: analysis based on depth of invasion. World J Surg (2004) 1.06

Tissue engineering of small intestinal tissue using collagen sponge scaffolds seeded with smooth muscle cells. Tissue Eng (2006) 1.05

Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol (2010) 1.03

Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology (2003) 1.02

Clinicopathologic characteristics and prognosis of synchronous multifocal gastric carcinomas. Am J Surg (2005) 1.01

The surgical procedure and clinical results of subtotal stomach preserving pancreaticoduodenectomy (SSPPD) in comparison with pylorus preserving pancreaticoduodenectomy (PPPD). J Surg Oncol (2007) 0.98

Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol (2004) 0.98

Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer (2005) 0.98

Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers. Anticancer Res (2003) 0.98

Acute peritonitis caused by intraperitoneal rupture of an infected urachal cyst: report of a case. Surg Today (2003) 0.98

The natural history of free cancer cells in the peritoneal cavity. Recent Results Cancer Res (2007) 0.96

Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer (2003) 0.96

Intrathoracic esophageal replacement by in situ tissue-engineered esophagus. J Thorac Cardiovasc Surg (2008) 0.95

Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res (2005) 0.92

Regeneration of skeletal muscle using in situ tissue engineering on an acellular collagen sponge scaffold in a rabbit model. ASAIO J (2007) 0.91

Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett (2004) 0.90

Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer. Gastric Cancer (2000) 0.89

Results of total gastrectomy with extended lymphadenectomy for gastric cancer in elderly patients. J Surg Oncol (2005) 0.89

Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. Int J Oncol (2004) 0.87

Characteristics of gastric carcinoma invading the muscularis propria. J Surg Oncol (2005) 0.86

Peritoneal cancer treatment. Expert Opin Pharmacother (2014) 0.85

Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers. Hepatogastroenterology (2004) 0.85

Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor. Dig Surg (2003) 0.85

REG gene expression is associated with the infiltrating growth of gastric carcinoma. Cancer (2003) 0.85

Intratumoral administration of methotrexate bound to activated carbon particles: antitumor effectiveness against human colon carcinoma xenografts and acute toxicity in mice. J Pharmacol Exp Ther (2004) 0.85

[Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of advanced rectal cancer, when surgical treatment was contraindicated]. Gan To Kagaku Ryoho (2002) 0.84

Dextran sulfate suppresses cell adhesion and cell cycle progression of melanoma cells. Anticancer Res (2005) 0.84

Regeneration of peritoneum using amniotic membrane to prevent postoperative adhesions. Hepatogastroenterology (2009) 0.83

Tumor recurrence and its timing following curative resection of early gastric carcinoma. Anticancer Res (2003) 0.83

Combination of L-3-phosphoserine phosphatase and CEA using real-time RT-PCR improves accuracy in detection of peritoneal micrometastasis of gastric cancer. Anticancer Res (2004) 0.83

Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an effective therapy in advanced gastric cancer. Anticancer Drugs (2002) 0.83

Efficacy of prophylactic extended lymphadenectomy with gastrectomy for patients with node-negative advanced gastric carcinoma. Hepatogastroenterology (2008) 0.83

Clinicopathologic and prognostic characterization of poorly differentiated medullary-type gastric adenocarcinoma. World J Surg (2004) 0.82

Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy. World J Gastroenterol (2006) 0.82

Resection of a pelvic schwannoma with partial removal of the sacral nerve root. Hepatogastroenterology (2003) 0.82

Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. Anticancer Res (2006) 0.82

Development of a novel antiadhesive material, alginate flakes, ex vivo and in vivo. Surg Today (2011) 0.81

The anti-adhesive effect of thermally cross-linked gelatin film and its influence on the intestinal anastomosis in canine models. J Biomed Mater Res B Appl Biomater (2012) 0.81

Pancreatic fistula formation after pancreaticooduodenectomy; for prevention of this deep surgical site infection after pancreatic surgery. Hepatogastroenterology (2009) 0.80

Restoration of RUNX3 enhances transforming growth factor-beta-dependent p21 expression in a biliary tract cancer cell line. Cancer Sci (2007) 0.80

Outcomes of total pelvic exenteration for colorectal cancer. Hepatogastroenterology (2010) 0.80

Reduction of air leaks in a canine model of pulmonary resection with a new staple-line buttress. J Thorac Cardiovasc Surg (2011) 0.80

Manifestation of bilateral huge ovarian metastases from colon cancer immediately after the initial operation: report of a case. Surg Today (2002) 0.80

Histologic and electrophysiological study of nerve regeneration using a polyglycolic acid-collagen nerve conduit filled with collagen sponge in canine model. Urology (2009) 0.79

[Screening of novel biomarkers for the detection of intraperitoneally disseminated cancer cells using human cDNA microarray]. Gan To Kagaku Ryoho (2002) 0.79

Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type. Pathol Res Pract (2002) 0.78

[An early detection of recurrence using reverse transcriptase-polymerase chain reaction (RT-PCR) and methylation-specific polymerase chain reaction (MSP) from peripheral blood in patients after gastrectomy]. Gan To Kagaku Ryoho (2006) 0.78

Endocrine cell and nerve regeneration in autologous in situ tissue-engineered small intestine. J Surg Res (2006) 0.78

[Analysis of Reg IV expression in peritoneal dissemination of gastric cancer using real-time RT-PCR]. Gan To Kagaku Ryoho (2005) 0.78

Long-term Helicobacter pylori colonization produces G cell hyperplasia and carcinoid tumor in Mongolian gerbils. J Cell Mol Med (2002) 0.77

Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer. Ann Surg Oncol (2006) 0.77

Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma. J Surg Oncol (2003) 0.77

Monoclonal antibody conjugated to gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma. J Surg Oncol (2006) 0.77

Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression. Cancer Gene Ther (2005) 0.77

Successful treatment of intractable esophagothoracic fistula using covered self-expandable stent. Hepatogastroenterology (2003) 0.77

[Functional analysis of peritoneal lymphoid tissues by GFP expression in mice--possible application for targeting gene therapy against peritoneal dissemination]. Gan To Kagaku Ryoho (2002) 0.77

Local administration of methotrexate bound to activated carbon particles (MTX-CH) for treating cancers in mice. Anticancer Res (2003) 0.77

[Quantification of circulating plasma DNA fragments as tumor markers in patients with esophageal and gastric cancer]. Gan To Kagaku Ryoho (2007) 0.77

Effect of hospital volume on long-term outcomes of laparoscopic gastrectomy for clinical stage I gastric cancer. Anticancer Res (2013) 0.76

Biodegradation of polyglycolic acid-collagen composite tubes for nerve guide in the peritoneal cavity. ASAIO J (2003) 0.76

Laparoscope-assisted superlow anterior resection combined with inter sphincteric rectal dissection for very low advanced rectal cancers combined with preoperative chemotherapy. Hepatogastroenterology (2009) 0.76

5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases. Asian Pac J Cancer Prev (2016) 0.76

[Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer]. Gan To Kagaku Ryoho (2005) 0.76

An extrarenal malignant rhabdoid tumor suspected to originate from the mesentery in an adult: report of a case. Surg Today (2003) 0.76

Huge ovarian metastasis from jejunal cancer occurring immediately after initial operation. Hepatogastroenterology (2005) 0.76

Results of combined complete removal of directly invaded organs with the stomach in patients with advanced gastric cancer. Hepatogastroenterology (2002) 0.75

Endocrine differentiation of rat enterocytes in long-term three-dimensional co-culture with intestinal myofibroblasts. In Vitro Cell Dev Biol Anim (2011) 0.75

[Possible involvement of inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers]. Gan To Kagaku Ryoho (2003) 0.75

Recurrent Male Breast Cancer Accompanied by Carcinomatous Pleuritis That Responded to Combination Therapy with High-Dose Toremifene and Docetaxel. Breast Care (Basel) (2010) 0.75

[A case of Castleman disease arising from lesser sac]. Nihon Shokakibyo Gakkai Zasshi (2004) 0.75

[Fundamental studies on locally injected methotrexate bound to activated carbon particles (MTX-CH)]. Gan To Kagaku Ryoho (2004) 0.75

[A case of postoperative pelvic metastasis and multiple liver metastases of the rectal cancer successfully treated by arterial infusion therapy with 5-FU/leucovorin]. Gan To Kagaku Ryoho (2004) 0.75

[Over expression of Reg IV in peritoneal dissemination of gastric cancer]. Gan To Kagaku Ryoho (2004) 0.75

[Efficacy of intra-peritoneal and intra-venous injection of monoclonal antibody A7-NCS conjugates against peritoneal dissemination of the gastric cancer]. Gan To Kagaku Ryoho (2004) 0.75

[Intratumoral administration of methotrexate bound to activated carbon particles (MTX-CH) inducing antitumor effect in vivo]. Gan To Kagaku Ryoho (2003) 0.75

A case of Castleman's disease arising from the lesser omentum. Hepatogastroenterology (2005) 0.75

Myeloid/NK cell acute leukemia with unique blast morphology: de novo or secondary leukemia? Int J Hematol (2013) 0.75

[A case report of esophageal cancer with tracheoesophageal fistula--improving the quality of life by using a covered self-expandable metallic stent]. Gan To Kagaku Ryoho (2005) 0.75

[Intraperitoneal chemotherapy against peritoneal carcinomatosis of gastric cancer with activated carbon particles adsorbing mitomycin C for four patients]. Gan To Kagaku Ryoho (2004) 0.75

[A trial of the new procedure of sentinel node biopsy in the lower rectal cancer by a transsacral approach]. Gan To Kagaku Ryoho (2004) 0.75

Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma. Cancer Immunol Immunother (2005) 0.75

[A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib]. Gan To Kagaku Ryoho (2005) 0.75

[Nobel genes improve accuracy in detection of peritoneal micro-metastasis of gastric cancer to decide indication for chemotherapy]. Gan To Kagaku Ryoho (2004) 0.75

[Intrahepatic arterial chemotherapy with 5-fluorouracil and intramuscular interferon-alpha for a patient with diffuse type of hepatocellular carcinoma]. Gan To Kagaku Ryoho (2004) 0.75

Transanal excision of a large rectal polyp assisted by transsacral manipulation of the rectum. Dis Colon Rectum (2004) 0.75

[Surgery for colorectal cancer aimed at improving postoperative quality of life]. Nihon Rinsho (2003) 0.75

[A case of unresectable multiple liver metastases from colon cancer successfully treated by hepatic arterial infusion chemotherapy and systemic immunotherapy (IFNANK) followed by hepatic resection]. Gan To Kagaku Ryoho (2004) 0.75

[Multiple hepatocellular carcinomas successfully treated by combined therapies]. Gan To Kagaku Ryoho (2005) 0.75

[Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR]. Gan To Kagaku Ryoho (2004) 0.75